Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Terns Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +3 vs. Q2 2022
- Shares held
- 30.3M
- +15.6M (+105.7%) vs. Q2 2022
- Total value
- $178.1M
- +$141.6M (+388.3%) vs. Q2 2022
- New holders
- 16
- 18 more added
- Sold out
- 13
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 7,481,204 | $44.1M | 0.88% | +3,690,000+97.3% | Added |
| Vivo Capital, LLC | 5,899,372 | $34.7M | 3.84% | +3,224,239+120.5% | Added |
| VR Adviser, LLC | 3,707,891 | $21.8M | 3.37% | +3,707,891 | New |
| Fairmount Funds Management LLC | 2,050,000 | $12.1M | 2.23% | +2,050,000 | New |
| Deerfield Management Company, L.P. (Series C) | 1,860,000 | $11.0M | 0.22% | +1,860,000 | New |
| Driehaus Capital Management LLC | 1,597,929 | $9.41M | 0.14% | +1,387,855+660.7% | Added |
| JPMorgan Chase & Co | 919,042 | $5.41M | 0.00% | +918,079+95,335.3% | Added |
| Ikarian Capital, LLC | 904,119 | $5.33M | 2.66% | +204,119+29.2% | Added |
| Pura Vida Investments, LLC | 728,600 | $4.29M | 0.65% | +728,600 | New |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $4.21M | 1.53% | 00.0% | Unchanged |
| Barclays PLC | 659,098 | $3.88M | 0.00% | +645,973+4,921.7% | Added |
| Vanguard Group Inc | 619,132 | $3.65M | 0.00% | +251,603+68.5% | Added |
| Armistice Capital, LLC | 600,000 | $3.53M | 0.09% | +276,984+85.7% | Added |
| Millennium Management LLC | 382,713 | $2.25M | 0.00% | +105,025+37.8% | Added |
| Acuta Capital Partners, LLC | 350,702 | $2.07M | 0.92% | +350,702 | New |
| Samsara BioCapital, LLC | 289,068 | $1.70M | 0.40% | 00.0% | Unchanged |
| BlackRock Inc. | 286,293 | $1.69M | 0.00% | +136,765+91.5% | Added |
| Commodore Capital LP | 205,870 | $1.21M | 0.20% | +205,870 | New |
| Geode Capital Management, LLC | 168,848 | $994.0K | 0.00% | +89,524+112.9% | Added |
| Renaissance Technologies LLC | 152,200 | $896.0K | 0.00% | −32,216−17.5% | Reduced |
| Boothbay Fund Management, LLC | 135,719 | $799.0K | 0.03% | +29,007+27.2% | Added |
| FMR LLC | 101,639 | $599.0K | 0.00% | −360.0% | Reduced |
| HighVista Strategies LLC | 77,344 | $456.0K | 0.26% | +77,344 | New |
| Bridgeway Capital Management, LLC | 69,500 | $409.0K | 0.01% | +24,000+52.7% | Added |
| State Street Corp | 42,037 | $248.0K | 0.00% | +22,200+111.9% | Added |
| Caas Capital Management LP | 85,851 | $213.0K | 0.03% | −11,661−12.0% | Reduced |
| Dimensional Fund Advisors LP | 33,312 | $196.0K | 0.00% | +33,312 | New |
| Northern Trust Corp | 21,504 | $127.0K | 0.00% | +7,131+49.6% | Added |
| Raymond James Financial Services Advisors, Inc. | 20,830 | $123.0K | 0.00% | +20,830 | New |
| Silverarc Capital Management, LLC | 14,473 | $85.0K | 0.04% | +14,473 | New |
| Jane Street Group, LLC | 13,255 | $78.0K | 0.00% | +13,255 | New |
| Acadian Asset Management LLC | 12,627 | $74.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 12,408 | $74.0K | 0.00% | +12,408 | New |
| Walleye Capital LLC | 12,124 | $71.0K | 0.00% | +12,124 | New |
| Goldman Sachs Group Inc | 11,916 | $70.0K | 0.00% | −4,672−28.2% | Reduced |
| Qube Research & Technologies Ltd | 10,809 | $64.0K | 0.00% | −599−5.3% | Reduced |
| Prelude Capital Management, LLC | 10,945 | $64.0K | 0.00% | +10,945 | New |
| Bank of America Corp | 7,726 | $46.0K | 0.00% | −10,382−57.3% | Reduced |
| Morgan Stanley | 7,243 | $42.0K | 0.00% | −11,428−61.2% | Reduced |
| Tower Research Capital LLC (TRC) | 6,601 | $39.0K | 0.00% | −3,879−37.0% | Reduced |
| UBS Group AG | 3,667 | $22.0K | 0.00% | +3,667 | New |
| Citigroup Inc | 701 | $4.00K | 0.00% | +182+35.1% | Added |
| China Universal Asset Management Co., Ltd. | 353 | $2.00K | 0.00% | +353 | New |
| Wells Fargo & Company | 122 | $1.00K | 0.00% | +70+134.6% | Added |
| Capital Advisors, Ltd. LLC | 200 | $1.00K | 0.00% | +98+96.1% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,261,435−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −1,238,800−100.0% | Sold out |
| Antara Capital LP | 0 | $0 | 0.00% | −874,600−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −401,268−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −63,454−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −57,876−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −38,810−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −20,300−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −2,428−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −118−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −14,097−100.0% | Sold out |